MEDIPOST participated in the ‘International Biotechnology Exhibition∙Conference (Biotech Japan 2015)’ held on May 13 to 15 in Tokyo Japan.

In this occasion, MEDIPOST publicized the local clinical test plan and global marketing strategy etc. on authritis medicine ‘CARTISTEM^®’, jointly with VICX company as the Japanese advisor.

Also, MEDIPOST announced the Japan-launch plan of ‘CARTISTEM^®’ to the audience from large pharmacy and bio enterprises in Asia and Europe, and held one on one meeting to have advance discussion on possible alliance.

‘Biotech Japan’ is the largest event related to bio business in Japan, celebrating 14th occasion since 2002. In this year the event was hold as part of ‘Life Science World 2015’, comprising 630 worldwide corporates, universities and research institutes etc.

MEDIPOST mentioned that “through this event, MEDIPOST anticipates to publicize the superb efficacy of ‘CARTISTEM^®’ to major global pharmaceutical companies who have entered in Asian zone at this occasion, and to enhance the company’s recognition within Japan”.

MEDIPOST is planning to apply for clinical trial on ‘CARTISTEM^®’ to Japanese PMDA